| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Departments of Clinical Chemistry and Pharmacology, School of Medicine, University of Crete, Iraklion, GR-711 10, Crete, Greece
Address all correspondence and requests for reprints to: Andrew N. Margioris, Department of Clinical Chemistry, School of Medicine, University of Crete, Iraklion, GR-711 10, Crete, Greece. E-mail: andym{at}med.uch.gr
The adrenal medulla of several species and some human pheochromocytomas
contain CRH. The first aim of the present work was to find out whether
normal rat adrenal chromaffin cells and the PC12 rat pheochromocytoma
cell line produce CRH in vitro and what regulates its
production. CRH was measured and characterized in the media of both
types of chromaffin cells under basal conditions and after exposure to
K+, nicotine, interleukin-1ß, and nerve growth factor
(NGF). The second aim was to examine the biological effect of exogenous
CRH (and of its antagonist) on the production of catecholamines from
these two types of cells. Our results are as follows: 1) Both types of
chromaffin cells contained and secreted comparable amounts of
immunoreactive-CRH under basal conditions and after
K+-induced depolarization, nicotine, and interleukin-1ß;
2) the physicochemical characteristics of the immunoreactive-CRH in the
cells and the media were identical to the putative CRH peptide on both
sieve chromatography and RP-HPLC; 3) synthetic CRH induced the
production of catecholamines from both cell types in a dose- and
time-dependent manner; this effect was abolished by the antagonist,
helical CRH; 4) exposure of PC12 cells to NGF (for 1 week) resulted in
their neuronal differentiation and the stimulation of their production
of CRH by 30 times and of dopamine by 10 times, compared with parallel
controls; this effect of NGF was abolished by
helical CRH. In
conclusion, our data suggest that the production of CRH by PC12 cells
represents the preservation of a normal chromaffin cell characteristic
rather than a tumor-induced ectopic phenomenon.
This article has been cited by other articles:
![]() |
E. Dermitzaki, C. Tsatsanis, V. Minas, E. Chatzaki, I. Charalampopoulos, M. Venihaki, A. Androulidaki, M. Lambropoulou, J. Spiess, E. Michalodimitrakis, et al. Corticotropin-Releasing Factor (CRF) and the Urocortins Differentially Regulate Catecholamine Secretion in Human and Rat Adrenals, in a CRF Receptor Type-Specific Manner Endocrinology, April 1, 2007; 148(4): 1524 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Charalampopoulos, C. Tsatsanis, E. Dermitzaki, V.-I. Alexaki, E. Castanas, A. N. Margioris, and A. Gravanis Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins PNAS, May 25, 2004; 101(21): 8209 - 8214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agelaki, C. Tsatsanis, A. Gravanis, and A. N. Margioris Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice Infect. Immun., November 1, 2002; 70(11): 6068 - 6074. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dermitzaki, C. Tsatsanis, A. Gravanis, and A. N. Margioris Corticotropin-releasing Hormone Induces Fas Ligand Production and Apoptosis in PC12 Cells via Activation of p38 Mitogen-activated Protein Kinase J. Biol. Chem., March 29, 2002; 277(14): 12280 - 12287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Preil, M. B. Muller, A. Gesing, J. M. H. M. Reul, I. Sillaber, M. M. van Gaalen, J. Landgrebe, F. Holsboer, M. Stenzel-Poore, and W. Wurst Regulation of the Hypothalamic-Pituitary-Adrenocortical System in Mice Deficient for CRH Receptors 1 and 2 Endocrinology, November 1, 2001; 142(11): 4946 - 4955. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Jeong, L. Jacobson, K. Pacak, E. P. Widmaier, D. S. Goldstein, and J. A. Majzoub Impaired Basal and Restraint-Induced Epinephrine Secretion in Corticotropin-Releasing Hormone- Deficient Mice Endocrinology, March 1, 2000; 141(3): 1142 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text] |
||||
![]() |
M. Venihaki, K. Ain, E. Dermitzaki, A. Gravanis, and A. N. Margioris KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone Endocrinology, February 1, 1998; 139(2): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Seth and J. A. Majzoub Repressor Element Silencing Transcription Factor/Neuron-restrictive Silencing Factor (REST/NRSF) Can Act as an Enhancer as Well as a Repressor of Corticotropin-releasing Hormone Gene Transcription J. Biol. Chem., April 20, 2001; 276(17): 13917 - 13923. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |